NIH-funded research Sbir 1 grant

Creating a non-invasive test to detect gestational diabetes early

Official title: Development and Validation of a Non-Invasive Microbiome-Based Diagnostic Tool for Early Detection of Gestational Diabetes Mellitus

Funded at Brooklyn Innoseq INC. · NIH-10921940 · Data updated 2026-11-12

This study is working on a new, easy test that looks at the bacteria in the gut of pregnant women to find out if they might have gestational diabetes earlier than current methods, helping moms-to-be get the care they need sooner.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionBrooklyn Innoseq INC.
NIH-funded
Lab location1 site (Brooklyn, UNITED STATES)
Project startJuly 22, 2024
Project endJune 30, 2025
Funding year2024
Award (this year)$296,351
NIH project number1R43HD115494-01
Project IDNIH-10921940 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant women, particularly those in their first or second trimester, who may be at risk for developing gestational diabetes.

Less likely to help

Patients who are not pregnant or those who have already been diagnosed with gestational diabetes may not benefit from this research.

What this research studies

This research focuses on developing a microbial screening test that can detect gestational diabetes mellitus (GDM) earlier than current methods. By analyzing the microbiome of pregnant women, the study aims to identify specific microbial biomarkers associated with GDM. This innovative approach utilizes machine learning technologies to enhance the accuracy of predictions, allowing for earlier intervention and management of diabetes during pregnancy. The test is designed to be non-invasive, making it more accessible for expectant mothers.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and prevention of gestational diabetes, improving health outcomes for both mothers and their babies.

How similar studies have gone: While the approach of using microbiome profiling for early detection of GDM is innovative, similar methodologies have shown promise in other areas of diabetes research.

Where this research is happening

  • Brooklyn Innoseq INC.
    Brooklyn, United States
    Active

Researchers

  • Principal investigator: Fan, Nini — Brooklyn Innoseq INC.
  • Study coordinator: Fan, Nini

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.